Ann: SYNLAB Agreements Signed in Turkiye and Czech Republic, page-2

As per Bells today :

Microba (MAP) today announce additional distribution agreements with SYNLAB affiliate organisations in Türkiye (formerly Turkey) and Czech Republic

Back in 2020, SYNLAB International GmbH and SYNLAB Diagnosticos Globales signed a distribution agreement with MAP to deliver Microba’s gut health tests to Healthcare Providers in Spain, with an option to formalise distribution agreements across their affiliate organisations. In December last year we communicated the activation of this option into Italy and Portugal. Synlab has now activated further agreements by way of its affiliate organisations Referans M-B Saglik Labopratuvar and SYNLAB czech s.r.o., to distribute Microba’s testing technology into Türkiye and Czech Republic respectively (non-exclusive distribution rights out to 31 December 2028).

This evolving distribution expansion is testament to MAPs significance as a leading gut health testing and precision microbiome company.

We currently have a Buy (Spec.) recommendation and a valuation of $0.60 p/s on the stock.